Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children : protocol for randomised controlled trial {1}

Background: The World Health Organization recommends universal iron supplementation for children aged 6–23 months in countries where anaemia is seen in over 40% of the population. Conventional ferrous salts have low efficacy due to low oral absorption in children with inflammation. Haem iron is more bioavailable, and its absorption may not be decreased by inflammation. This study aims to compare daily supplementation with haem iron versus ferrous sulphate on haemoglobin concentration and serum ferritin concentration after 12 weeks of supplementation. Methods: This will be a two-arm, randomised controlled trial. Gambian children aged 6–12 months with anaemia will be recruited within a predefined geographical area and recruited by trained field workers. Eligible participants will be individually randomised using a 1:1 ratio within permuted blocks to daily supplementation for 12 weeks with either 10.0 mg of elemental iron as haem or ferrous sulphate. Safety outcomes such as diarrhoea and infection-related adverse events will be assessed daily by the clinical team (see Bah et al. Additional file 4_Adverse event eCRF). Linear regression will be used to analyse continuous outcomes, with log transformation to normalise residuals as needed. Binary outcomes will be analysed by binomial regression or logistic regression, Primary analysis will be by modified intention-to-treat (i.e., those randomised and who ingested at least one supplement dose of iron), with multiple imputations to replace missing data. Effect estimates will be adjusted for baseline covariates (C-reactive protein, alpha-1-acid glycoprotein, haemoglobin, ferritin, soluble transferrin receptor). Discussion: This study will determine if therapeutic supplementation with haem iron is more efficacious than with conventional ferrous sulphate in enhancing haemoglobin and ferritin concentrations in anaemic children aged 6–12 months.

Saved in:
Bibliographic Details
Main Authors: Bah, Mamadou, Verhoef, Hans, Okoh, Emmanuel, Bah, Abdoulie, Prentice, Andrew M., Cerami, Carla
Format: Article/Letter to editor biblioteca
Language:English
Subjects:Anaemia, Gambia, Haem iron, Hepcidin, Infants, Iron deficiency, Iron status, Iron supplements, Safety,
Online Access:https://research.wur.nl/en/publications/haem-iron-versus-ferrous-iron-salts-to-treat-iron-deficiency-anae
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-wur-nl-wurpubs-629897
record_format koha
spelling dig-wur-nl-wurpubs-6298972024-12-04 Bah, Mamadou Verhoef, Hans Okoh, Emmanuel Bah, Abdoulie Prentice, Andrew M. Cerami, Carla Article/Letter to editor Trials 25 (2024) 1 ISSN: 1745-6215 Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children : protocol for randomised controlled trial {1} 2024 Background: The World Health Organization recommends universal iron supplementation for children aged 6–23 months in countries where anaemia is seen in over 40% of the population. Conventional ferrous salts have low efficacy due to low oral absorption in children with inflammation. Haem iron is more bioavailable, and its absorption may not be decreased by inflammation. This study aims to compare daily supplementation with haem iron versus ferrous sulphate on haemoglobin concentration and serum ferritin concentration after 12 weeks of supplementation. Methods: This will be a two-arm, randomised controlled trial. Gambian children aged 6–12 months with anaemia will be recruited within a predefined geographical area and recruited by trained field workers. Eligible participants will be individually randomised using a 1:1 ratio within permuted blocks to daily supplementation for 12 weeks with either 10.0 mg of elemental iron as haem or ferrous sulphate. Safety outcomes such as diarrhoea and infection-related adverse events will be assessed daily by the clinical team (see Bah et al. Additional file 4_Adverse event eCRF). Linear regression will be used to analyse continuous outcomes, with log transformation to normalise residuals as needed. Binary outcomes will be analysed by binomial regression or logistic regression, Primary analysis will be by modified intention-to-treat (i.e., those randomised and who ingested at least one supplement dose of iron), with multiple imputations to replace missing data. Effect estimates will be adjusted for baseline covariates (C-reactive protein, alpha-1-acid glycoprotein, haemoglobin, ferritin, soluble transferrin receptor). Discussion: This study will determine if therapeutic supplementation with haem iron is more efficacious than with conventional ferrous sulphate in enhancing haemoglobin and ferritin concentrations in anaemic children aged 6–12 months. en application/pdf https://research.wur.nl/en/publications/haem-iron-versus-ferrous-iron-salts-to-treat-iron-deficiency-anae 10.1186/s13063-024-08101-0 https://edepot.wur.nl/657815 Anaemia Gambia Haem iron Hepcidin Infants Iron deficiency Iron status Iron supplements Safety https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/ Wageningen University & Research
institution WUR NL
collection DSpace
country Países bajos
countrycode NL
component Bibliográfico
access En linea
databasecode dig-wur-nl
tag biblioteca
region Europa del Oeste
libraryname WUR Library Netherlands
language English
topic Anaemia
Gambia
Haem iron
Hepcidin
Infants
Iron deficiency
Iron status
Iron supplements
Safety
Anaemia
Gambia
Haem iron
Hepcidin
Infants
Iron deficiency
Iron status
Iron supplements
Safety
spellingShingle Anaemia
Gambia
Haem iron
Hepcidin
Infants
Iron deficiency
Iron status
Iron supplements
Safety
Anaemia
Gambia
Haem iron
Hepcidin
Infants
Iron deficiency
Iron status
Iron supplements
Safety
Bah, Mamadou
Verhoef, Hans
Okoh, Emmanuel
Bah, Abdoulie
Prentice, Andrew M.
Cerami, Carla
Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children : protocol for randomised controlled trial {1}
description Background: The World Health Organization recommends universal iron supplementation for children aged 6–23 months in countries where anaemia is seen in over 40% of the population. Conventional ferrous salts have low efficacy due to low oral absorption in children with inflammation. Haem iron is more bioavailable, and its absorption may not be decreased by inflammation. This study aims to compare daily supplementation with haem iron versus ferrous sulphate on haemoglobin concentration and serum ferritin concentration after 12 weeks of supplementation. Methods: This will be a two-arm, randomised controlled trial. Gambian children aged 6–12 months with anaemia will be recruited within a predefined geographical area and recruited by trained field workers. Eligible participants will be individually randomised using a 1:1 ratio within permuted blocks to daily supplementation for 12 weeks with either 10.0 mg of elemental iron as haem or ferrous sulphate. Safety outcomes such as diarrhoea and infection-related adverse events will be assessed daily by the clinical team (see Bah et al. Additional file 4_Adverse event eCRF). Linear regression will be used to analyse continuous outcomes, with log transformation to normalise residuals as needed. Binary outcomes will be analysed by binomial regression or logistic regression, Primary analysis will be by modified intention-to-treat (i.e., those randomised and who ingested at least one supplement dose of iron), with multiple imputations to replace missing data. Effect estimates will be adjusted for baseline covariates (C-reactive protein, alpha-1-acid glycoprotein, haemoglobin, ferritin, soluble transferrin receptor). Discussion: This study will determine if therapeutic supplementation with haem iron is more efficacious than with conventional ferrous sulphate in enhancing haemoglobin and ferritin concentrations in anaemic children aged 6–12 months.
format Article/Letter to editor
topic_facet Anaemia
Gambia
Haem iron
Hepcidin
Infants
Iron deficiency
Iron status
Iron supplements
Safety
author Bah, Mamadou
Verhoef, Hans
Okoh, Emmanuel
Bah, Abdoulie
Prentice, Andrew M.
Cerami, Carla
author_facet Bah, Mamadou
Verhoef, Hans
Okoh, Emmanuel
Bah, Abdoulie
Prentice, Andrew M.
Cerami, Carla
author_sort Bah, Mamadou
title Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children : protocol for randomised controlled trial {1}
title_short Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children : protocol for randomised controlled trial {1}
title_full Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children : protocol for randomised controlled trial {1}
title_fullStr Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children : protocol for randomised controlled trial {1}
title_full_unstemmed Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children : protocol for randomised controlled trial {1}
title_sort haem iron versus ferrous iron salts to treat iron deficiency anaemia in gambian children : protocol for randomised controlled trial {1}
url https://research.wur.nl/en/publications/haem-iron-versus-ferrous-iron-salts-to-treat-iron-deficiency-anae
work_keys_str_mv AT bahmamadou haemironversusferrousironsaltstotreatirondeficiencyanaemiaingambianchildrenprotocolforrandomisedcontrolledtrial1
AT verhoefhans haemironversusferrousironsaltstotreatirondeficiencyanaemiaingambianchildrenprotocolforrandomisedcontrolledtrial1
AT okohemmanuel haemironversusferrousironsaltstotreatirondeficiencyanaemiaingambianchildrenprotocolforrandomisedcontrolledtrial1
AT bahabdoulie haemironversusferrousironsaltstotreatirondeficiencyanaemiaingambianchildrenprotocolforrandomisedcontrolledtrial1
AT prenticeandrewm haemironversusferrousironsaltstotreatirondeficiencyanaemiaingambianchildrenprotocolforrandomisedcontrolledtrial1
AT ceramicarla haemironversusferrousironsaltstotreatirondeficiencyanaemiaingambianchildrenprotocolforrandomisedcontrolledtrial1
_version_ 1819140602621591552